Scott M. Coiante

Companies

• Lexicon PharmaceuticalsChief financial officer Jan 2, 2025 to now¹
• AGILE THERAPEUTICS INCChief financial officer May 22, 2014 to Aug 26, 2024²
• Aprea Therapeutics, Inc.Chief financial officer Oct 2, 2019 to Aug 1, 2022³
• Aprea Therapeutics, Inc.Board member Mar 14, 2022 to Jun 7, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LPLexicon Pharmaceuticals LXRX105,356 shares⁵$173.8K at $1.65Feb 28, 2026
• ATAprea Therapeutics, Inc. APRE145,065 shares⁶$84.7K at $0.58Jul 28, 2022
• ATAGILE THERAPEUTICS INC0 shares⁷Aug 26, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 28, 2026Shares withheld for tax 54,881 shares at $1.47 of Lexicon Pharmaceuticals⁵
• Feb 28, 2026Exercised options 160,237 shares of Lexicon Pharmaceuticals⁵
• Aug 26, 2024Returned to company 5,080 shares at $1.52 of AGILE THERAPEUTICS INC⁷
• Aug 26, 2024Returned to company 15,000 shares at $1.52 of AGILE THERAPEUTICS INC⁷
• Oct 3, 2023Granted 20,000 shares of AGILE THERAPEUTICS INC⁸
• Jul 28, 2022Granted 60,800 shares of Aprea Therapeutics, Inc.⁶
• Jun 3, 2022Shares withheld for tax 35,284 shares at $0.81 of Aprea Therapeutics, Inc.⁹
• Mar 10, 2022Granted 42,900 shares of Aprea Therapeutics, Inc.¹⁰
• Feb 25, 2022Shares withheld for tax 14,817 shares at $1.74 of Aprea Therapeutics, Inc.¹¹